Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Mussetti

Showing results (31-40 of 100) with videos related to

Pageof 10
Sort By:
Journal of Clinical Medicine|December 23, 2022
Progress in Hematopoietic Stem Cell Transplantation and Cellular TherapiesDiana Cenariu, Horia Bumbea, Anca Colita, et al.
Pediatric Hematology and Oncology|October 8, 2016
Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donorsAlberto Mussetti, Nancy A Kernan, Susan E Prockop, et al.
Bone Marrow Transplantation|July 7, 2015
Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraAlberto Mussetti, Sean M Devlin, Hugo R Castro-Malaspina, et al.
The Lancet. Haematology|November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approachPeter Dreger, Paolo Corradini, John G Gribben, et al.
Ejhaem|July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphomaClara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2012
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantationVittorio Montefusco, Francesco Spina, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy PatientMaría Bonilla-Moreno, Miriam Torrecillas, Julia Laporte-Amargos, et al.
JMIR Formative Research|June 4, 2024
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center StudyLidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle, et al.
Cancer|May 26, 2017
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk allelesNiccolo Bolli, Matteo Barcella, Erika Salvi, et al.
Pageof 10

Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
Journal of Clinical Medicine|December 23, 2022
Progress in Hematopoietic Stem Cell Transplantation and Cellular TherapiesDiana Cenariu, Horia Bumbea, Anca Colita, et al.
Pediatric Hematology and Oncology|October 8, 2016
Allogeneic hematopoietic stem cell transplantation for nonmalignant hematologic disorders using chemotherapy-only cytoreductive regimens and T-cell-depleted grafts from human leukocyte antigen-matched or -mismatched donorsAlberto Mussetti, Nancy A Kernan, Susan E Prockop, et al.
Bone Marrow Transplantation|July 7, 2015
Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab eraAlberto Mussetti, Sean M Devlin, Hugo R Castro-Malaspina, et al.
The Lancet. Haematology|November 29, 2023
CD19-directed CAR T cells as first salvage therapy for large B-cell lymphoma: towards a rational approachPeter Dreger, Paolo Corradini, John G Gribben, et al.
Ejhaem|July 18, 2022
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphomaClara Maluquer, Beatriz Bellosillo, Alberto Mussetti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 13, 2012
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantationVittorio Montefusco, Francesco Spina, Francesca Patriarca, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 14, 2017
Haploidentical Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Post-Transplantation Cyclophosphamide Graft-versus-Host Disease ProphylaxisLuca Castagna, Alberto Mussetti, Raynier Devillier, et al.
Antimicrobial Agents and Chemotherapy|June 26, 2023
Development of Meropenem Resistance in a Multidrug-Resistant Campylobacter coli Strain Causing Recurrent Bacteremia in a Hematological Malignancy PatientMaría Bonilla-Moreno, Miriam Torrecillas, Julia Laporte-Amargos, et al.
JMIR Formative Research|June 4, 2024
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center StudyLidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle, et al.
Cancer|May 26, 2017
Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk allelesNiccolo Bolli, Matteo Barcella, Erika Salvi, et al.
Pageof 10